CTNNB1 and glioblastoma: Through this study, it is evident that targeting the CTNNB1/TCF and autophagy pathways behaves as a potential therapeutic option, indicating the importance of β-catenin and, ultimately, CTNNB1 in glioblastoma cell viability [146].